^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Sarcoma
    Drug:gemcitabine (DNA synthesis inhibitor) +
    docetaxel (Tubulin polymerization promoter, Microtubule stabilizer)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    ESMO.org
    Title:

    Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†

    Excerpt:
    Summary of recommendations...Chondrosarcoma...Doxorubicin and ifosfamide may prove active in CS, especially in high-grade lesions, and gemcitabine in combination with docetaxel has also been reported to be effective.
    DOI:
    10.1093/annonc/mdy096
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Uterine sarcoma: Other Recommended Regimens…Docetaxel/gemcitabine...